Prospective Human Study Evaluating Changes in Markers of Detoxification, Overall Physical and Mental Health, and Fatigue Following Supplementation With CellCore Protocols
Part of paid clinical trials in Richmond, Virginia.
- Sponsor
- OvationLab
- Study ID
- NCT07753798
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Environmental Toxins
- General Health
Eligibility Criteria
- Sex
- ALL
- Age
- 25 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- CellCore Foundational Protocol — DIETARY_SUPPLEMENTThe CellCore Foundational Protocol is a four-phase, four-month supplement program designed to support drainage, gut and immune balance, whole-body immune support, and systemic detoxification in a stepwise sequence.
- CellCore - BioToxin Binder & Drainage Activator — DIETARY_SUPPLEMENTBioToxin Binder is a first-step detox support supplement that uses CellCore BioActive Carbon® carbon technology to bind biotoxins while supporting gut microbiome balance, immunity, digestive function, cellular repair, and energy production. Drainage Activator is a drainage-support supplement aimed at the extracellular matrix and lymphatic drainage, using herbs and mushrooms to help open drainage pathways and support the body's natural detox processes. This is a three-month combination protocol.
Study Details
The primary purpose of this study is to evaluate the effects of CellCore protocols on environmental toxicant biomarkers among adult patients with high baseline toxicant levels. Patients will be allocated to one of two CellCore protocols (Foundational Protocol or BioToxin Binder/Drainage Activator) based on overall physical health, mental health, and fatigue levels at baseline. A prospective, practitioner-led, open-label, single-arm intervention with the CellCore protocols will be conducted to measure pre- and post-intervention changes in urinary environmental toxicant biomarkers and validated, patient-reported health outcomes.
Key Dates
- First listed
- Aug 10, 2026
- Start date
- Aug 31, 2026
- Status verified
- Aug 2026
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: CellCore - Foundational Protocol
- Experimental: CellCore - BioToxin Binder + Drainage Activator
Primary Outcome Measure
Mosaic Envirotox Burden + Heavy Metals Urinary Panel [ Time Frame: Measured at baseline, one month, and end of protocol (4 months for Foundational Protocol & 3 months for BioToxin Binder + Drainage Activator protocol) ]
Central Contacts
- Study Administrator(240) 232-2103
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| OvationLab | Richmond | Virginia | 23220 |
Find similar trials in Richmond, VA
Related Studies
- Collection and Analyses of Physiological, Physical, and Molecular Data From a Diverse PopulationRecruiting · Viome · Bothell, Washington
- Apple Health StudyRecruiting · Apple Inc. · Washington D.C., District of Columbia